Results 321 to 326 of about 154,739 (326)

The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature

Journal of Neuro-Oncology, 2020
Victor M. Lu, Kyle P. O'Connor, Ashish H. Shah, D. Eichberg, E. Luther, R. Komotar, Michael E. Ivan   +6 more
semanticscholar   +1 more source

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas

Acta Neuropathologica, 2018
M. Shirahata, T. Ono, D. Stichel, D. Schrimpf, D. Reuss, F. Sahm, C. Koelsche, A. Wefers, A. Reinhardt, Kristin Huang, P. Sievers, H. Shimizu, H. Nanjo, Yusuke Kobayashi, Yohei Miyake, Tomonari Suzuki, J. Adachi, K. Mishima, A. Sasaki, R. Nishikawa, M. Bewerunge-Hudler, M. Ryzhova, O. Absalyamova, A. Golanov, P. Sinn, M. Platten, C. Jungk, F. Winkler, A. Wick, D. Hänggi, A. Unterberg, S. Pfister, David T. W. Jones, M. Bent, M. Hegi, P. French, B. Baumert, R. Stupp, T. Gorlia, M. Weller, D. Capper, A. Korshunov, C. Herold‐Mende, W. Wick, D. Louis, A. Deimling   +45 more
semanticscholar   +1 more source

Astrocytoma, IDH mutant

2005
openaire   +1 more source

Heating Up IDH-Mutant Gliomas

New England Journal of Medicine
Michael Platten, Lukas Bunse
openaire   +2 more sources

EXABS-177-AML: IDH Inhibitor Combination Strategies in IDH-Mutated AML

Clinical Lymphoma Myeloma and Leukemia
Jennifer Marvin-Peek, Courtney DiNardo
openaire   +1 more source

Glioblastoma IDH-wildtype

2016
openaire   +1 more source